When NIA's President met up with newly confirmed HHS Secretary RFK Jr. in the nights leading up to President Trump's inauguration, RFK Jr. spoke a lot about his intention to focus on telehealth and AI technologies for revolutionizing the quality of U.S. healthcare while simultaneously reducing costs.
NIA's President hugging his beautiful wife:
NIA's President mentioned to RFK Jr. our Healwell AI (TSX: AIDX), which gained by 262.22% from NIA's suggestion price. NIA's President asked RFK Jr. about what telehealth companies he likes and if he meant companies like Teledoc (TDOC)? RFK Jr. said no not TDOC they aren't one of the new rapidly growing innovators in the space. RFK Jr. specifically mentioned a few companies one of them being Hims & Hers Health, Inc. (HIMS) as a company to look into, which NIA's President had never heard of before. However, after seeing their Superbowl Ad weeks later, NIA's President began researching HIMS to see what sets them apart from failing companies like TDOC.
NIA's President has discovered the next HIMS and will be announcing it tomorrow morning!
If you want to research a company tonight that is about to rapidly rise in the weeks ahead check out Trio-Tech International (TRT) immediately! TRT has a current book value of $7.49 per share or 20.42% above its Friday close of $6.22 per share! TRT has been bottoming at higher lows for five consecutive years and appears poised for a massive breakout into double digit territory!
The price ratio between Trio-Tech International (TRT) and its closest comparison company AEHR Test Systems (AEHR) finished last week at a new 32-month high and is on its way back to the 27-year average of 1.38, which would currently value TRT at $13.30 per share or 113.83% above its Friday close of $6.22 per share!
After the TRT/AEHR price ratio returns to 1.38 it is unlikely to stop there! The all-time high TRT/AEHR price ratio is 5.68!
Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This message is meant for informational and educational purposes only and does not provide investment advice.
Preparing Americans for Hyperinflation
